Amgen posts higher 2Q sales, profit to beat views

boston.com — TRENTON, N.J. (AP) - Amgen Inc.'s second-quarter net income rose 8 percent as the world's largest biotech company benefited from higher sales for its top-selling drugs and a gain from selling its share of an experimental medicine.
Linda Johnson Business Writer, Associated Press @LindaJ_onPharma
Amgen crushes Wall Street's 2Q expectations due to higher drugs sales, sale of drug rights, share buybacks: AP t.co/PEZMJzVk